Table I.
Molecular subtype | Index | Positive result |
---|---|---|
EBV+ | EBV positive | 6 |
PLK3CA mutation | 0 | |
Hypermethylation | 0 | |
JAK2 amplification | 0 | |
CD274 (PD-L1) amplification | 0 | |
PDCD1LG2 (PD-L2) amplification | 0 | |
MSI | MSI status | 15 |
Hypermutated | 0 | |
Hypermethylation | 0 | |
GS | RHOA mutation | 0 |
CLDN18-ARHGAP26 rearrangement | 0 | |
CLDN18-ARHGAP6 rearrangement | 0 | |
Absence of extensive somatic copy-number aberrations | 14 | |
CIN | Copy Number Cluster (Aneuploidy) | 30 |
Focal amplification of receptor tyrosine kinases (vascular endothelial growth factor receptor 2) | 0 |
EBV, Epstein-Barr virus; MSI, microsatellite instability; GS, gene stable; CIN, chromosome instability.